首页> 外文OA文献 >Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy

【2h】

Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy

机译：克隆血液血管瘤在多发性骨髓瘤患者中临床关联及预后抗冲自体后干细胞移植性活性维持治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kitsada Wudhikarn; Leslie Padrnos; Terra Lasho; Betsy LaPlant; Shaji Kumar; Angela Dispenzieri; Martha Lacy; S. Vincent Rajkumar; Morie Gertz; Abhishek A. Mangaonkar; Wilson Gonsalves; Rhett Ketterling; Chang‐Xin Shi; Rafael Fonseca; A. Keith Stewart; Mrinal M. Patnaik;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Updated Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM) [J] . Thomas Sheeba K., Shah Jatin J., Morphey Ashley N., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：多种骨髓瘤（PTS）中Lenalidomide-Elotuzumab作为维护治疗后患者（PTS）的维持治疗的II次级研究结果的更新结果
2. Canadian Cost Analysis Comparing Maintenance Therapy with Bortezomib Versus Lenalidomide for Patients with Multiple Myeloma Post Autologous Stem Cell Transplant [J] . R. LeBlanc, S. Hollmann, J. Tay Journal of population therapeutics and clinical pharmacology . 2016,第1期

机译：加拿大成本分析比较维持疗法与硼替佐米与来那度胺治疗自体干细胞移植后多发性骨髓瘤的疗效
3. Lenalidomide Maintenance Therapy after Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Multiple Myeloma Patients: Factors That Impact Treatment [J] . Pushpinderdeep Singh Kahlon, Nimrat Kaur Sandhu, Phillip Kuriakose, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：在多发性骨髓瘤患者中自体外周血干细胞移植（PBSCT）后的Lenalidomide维持治疗：影响治疗的因素
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Natural Killer Cell Recovery and Disease Outcomes After Autologous Stem Cell Transplantation in Multiple Myeloma [D] . Keruakous, Amany R. 2021

机译：自然杀手细胞回收和疾病结果在多发性骨髓瘤中的自体干细胞移植后
6. Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized open multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma [O] . Marc-Andrea Baertsch, Jana Schlenzka, Elias K. Mai, 2016

机译：德语德语骨髓瘤多中心小组（GMMG）试验ReLApsE的原理和设计：来那度胺/地塞米松与来那度胺/地塞米松联合随后自体干细胞移植和来那度胺维持治疗多发性骨髓瘤的患者的随机开放多中心III期试验
7. Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma [O] . Bärtsch, Marc-Andrea, Schlenzka, Jana, Mai, Elias K., 2017

机译：德语系骨髓瘤多中心小组（RelepsE）试验的原理和设计：来那度胺/地塞米松与来那度胺/地塞米松联合随后的自体干细胞移植和来那度胺维持治疗多发性骨髓瘤的患者的随机，开放，多中心III期试验

Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy

著录项

引文网络

相似文献

相关主题

期刊订阅